Remote Senior Oncology Growth Manager

Ladders; EE. UU.; A distancia; USD 150.000 - 230.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Competitive cash compensation

Robust equity awards

Strong benefits package

Learning and development opportunities

Descripción de la vacante

Ladders is seeking a Senior Oncology Account Manager for a remote US role focused on driving oncology portfolio adoption across the territory. The position emphasizes strategic account management, patient access support, and market-driven planning while engaging both virtual and in-person stakeholders.

Ideal candidates will have 12–15+ years in biopharma, 8–12+ years in oncology sales, and a track record launching oral oncolytics with companion diagnostics. Travel to the territory is required.

Formación

• 12–15+ years in biopharma industry required.
• 8–12+ years oncology product sales experience with proven track record.
• Experience launching oral oncolytics with companion diagnostics.
• Willingness to travel and reside in territory.

Responsabilidades

• Market the oncology product portfolio within the designated territory.
• Exceed performance goals by positioning benefits for appropriate patients.
• Collaborate with internal stakeholders to support patient access.
• Adapt engagement strategies between virtual and in-person interactions.
• Analyze market data to inform planning and optimize calls.
• Build and maintain relationships with healthcare customers.

Conocimientos

Oncology sales

Oral oncology launches

Strategic account management

Travel readiness

Educación

MA/MS/BA/BS with 12–15+ years in biopharma

Descripción del empleo

Ladders is seeking a Senior Oncology Account Manager for a remote US role focused on driving oncology portfolio adoption across the territory. The position emphasizes strategic account management, patient access support, and market-driven planning while engaging both virtual and in-person stakeholders.

Ideal candidates will have 12–15+ years in biopharma, 8–12+ years in oncology sales, and a track record launching oral oncolytics with companion diagnostics. Travel to the territory is required.